title: Transient narcolepsy-cataplexy syndrome after discontinuation of the antidepressant venlafaxine.
authors.forename: Christoph
authors.initials: C
authors.lastname: Nissen
authors.forename: Bernd
authors.initials: B
authors.lastname: Feige
authors.forename: Eric
authors.initials: E
authors.lastname: Nofzinger
authors.forename: Dieter
authors.initials: D
authors.lastname: Riemann
authors.forename: Mathias
authors.initials: M
authors.lastname: Berger
authors.forename: Ulrich
authors.initials: U
authors.lastname: Voderholzer
mesh_terms: D000328:Adult; D001714:Bipolar Disorder / Q000188:drug therapy*; D003511:Cyclohexanols / Q000009:adverse effects*; D003865:Major Depressive Disorder / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D019263:Dysthymic Disorder / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009290:Narcolepsy / Q000139:chemically induced* / Q000175:diagnosis; D017286:Polysomnography; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis / Q000209:etiology*; D017211:Treatment Failure; D000069470:Venlafaxine Hydrochloride
chemical_list: D003511:Cyclohexanols; D000069470:Venlafaxine Hydrochloride